Stanford RCC Program

The Kidney Cancer Research Program at Stanford University is a forum to encourage multidisciplinary approaches to basic and pre-clinical kidney cancer research.

[Stanford RCC Program @SKCRP]

Exciting work from Kuo and Davis Labs using #kidneycancer as a model now out in @PNASNews - Nanoparticle-enabled innate immune stimulation activates endogenous tumor-infiltrating T cells with broad antigen specificities https://t.co/DnJdfuuy8D @StanfordMed @Stanford @SKCRP

[Stanford RCC Program @SKCRP]

Drs Hoerner Chen & Fan review of glutaminase inhibition in #kidneycancer just released @KCA_Journal

The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy https://t.co/i0mIVcGaUX

@skcrp @StanfordMed @StanfordDeptMed

[Stanford RCC Program @SKCRP]

@Stanford senior Star Huynh presenting her experience in the Larry & Diana Lulofs internship in #kidneycancer research @StanfordUrology

[European Urology @EUplatinum]

Epidemiology of Renal Cell Carcinoma https://t.co/XLn5XxuoqV @u_capitanio

[Stanford RCC Program @SKCRP]

Dr. Hoerner presenting data at @stanfordurology grand rounds - limited intratumoral heterogeneity of protein activation level in multiregion sampling in #kidneycancer @SKCRP

[Stanford RCC Program @SKCRP]

Dr. Giaccia et al - Pre-metastatic niches: organ-specific homes for metastases - in @NatureRevCancer https://t.co/oAR5lBrB02

[Stanford RCC Program @SKCRP]

Dr. Giaccia and Aguilera - Oncologic Pathways and Their Role in T-cell Exclusion and Immune Evasion #kidneycancer https://t.co/9Cx6MQabKF

[Stanford RCC Program @SKCRP]

From Dr. Fan et al - cardiotoxicities of TKIs used for #kidneycancer in @ScienceTM https://t.co/YH826CBPQ4

[Stanford RCC Program @SKCRP]

From new @skcrp #kidneycancer single cell proteomics researcher- Dr. Fantl et al https://t.co/4cz8XHZr8X https://t.co/p9fhquPV6r

[Stanford RCC Program @SKCRP]

New from Dr. Chung et al - The incidence of unsuccessful partial nephrectomy in US #kidneycancer

[Stanford RCC Program @SKCRP]

Dr. Chung et al - Adoption of Robot-Assisted Partial Nephrectomies. #kidneycancer @JEndourology

[JASN_News @JASN_News]

Incident #CKD after Radical or Partial Nephrectomy
@StanfordNeph @johnleppert @RemyLamberts @gchertow
https://t.co/MqSo2jveyN

[Stanford RCC Program @SKCRP]

Inaugural @StanfordMed Larry and Diana Lulofs Memorial Kidney Cancer Research Internship presentation - @Stanford undergrad Jasmin Kamruddin

[Stanford RCC Program @SKCRP]

Dr. Felsher et al develop much needed mouse models of papillary and clear cell #kidneycancer @NatureComms
https://t.co/9jRupLruM0

[Sandy Srinivas @sandysrimd]

3rd CPI approved in Bladder cancer- durvalumab ( imfinzi)

[Kidney Cancer @KidneyCancer]

Here's where to get help finding a clinical trial for #kidneycancer https://t.co/uOP6vJ5GVg

[Stanford RCC Program @SKCRP]

Novel lincRNA SLINKY is a prognostic biomarker in #kidneycancer -Brooks et al. Featured in @OncotargetJrnl @SKCRP https://t.co/0u6tz9BN5W

[Stanford RCC Program @SKCRP]

New from Dr. Giaccia et al- AXL role in immune evasion in cancer #kidneycancer https://t.co/9Cx6MQabKF

[Stanford RCC Program @SKCRP]

Perspective: Beyond the Genome- The promise of epidemiology in #kindeycancer @johnleppert @chiragjp @NatureOutlook https://t.co/Q4Skku0Nn7